EV/EBITDA
-2.78
+0.03+1.07%
Thu, 27 Feb 2025 00:48:39 GMT
Summary
- As of February 27, 2025, MCRB EV/EBITDA is -2.78, with a rise of +0.03 (+1.07%) during the most recent trading day.
- Over the past year, MCRB EV/EBITDA has increased by +126.25 (+97.85%).
- MCRB EV/EBITDA is now -131.31% below its all-time high of 8.88.
Performance
MCRB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MCRB EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +1.1% | -1.1% | -1.3% |
1 m1 month | +8.6% | -8.5% | -10.1% |
3 m3 months | +7.6% | -7.6% | -9.0% |
6 m6 months | +52.2% | -41.8% | -10.9% |
ytdytd | +3.8% | -3.6% | -4.3% |
1 y1 year | +97.8% | -33.4% | -26.4% |
5 y5 years | +25.9% | -31.5% | -78.2% |
MCRB EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -3.4% | -3.04 | +8.6% | |
3 m | 3-month | -2.65 | -4.9% | -3.33 | +16.5% |
6 m | 6-month | -2.14 | -29.9% | -6.77 | +58.9% |
1 y | 1-year | 8.88 | -131.3% | -144.30 | +98.1% |
3 y | 3-year | 8.88 | -131.3% | -160.04 | +98.3% |
5 y | 5-year | 8.88 | -131.3% | -160.04 | +98.3% |
alltime | all time | 8.88 | -131.3% | -160.04 | +98.3% |
Seres Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -2.78(-3.8%) |
2024 | -2.89(-98.1%) |
2023 | -149.16(+4990.8%) |
2022 | -2.93(-73.8%) |
2021 | -11.19(-58.9%) |
Date | Value |
---|---|
2020 | -27.20(+664.0%) |
2019 | -3.56(+226.6%) |
2018 | -1.09(-76.1%) |
2017 | -4.57(+17.5%) |
2016 | -3.89(-83.8%) |
2015 | -23.97 |
FAQ
- What is Seres Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Seres Therapeutics?
- What is MCRB EV/EBITDA year-to-date change?
- What is Seres Therapeutics EV/EBITDA year-on-year change?
What is Seres Therapeutics EV/EBITDA?
The current EV/EBITDA of MCRB is -2.78
What is the all time high EV/EBITDA for Seres Therapeutics?
Seres Therapeutics all-time high EV/EBITDA is 8.88
What is MCRB EV/EBITDA year-to-date change?
Seres Therapeutics EV/EBITDA has changed by +0.11 (+3.81%) since the beginning of the year
What is Seres Therapeutics EV/EBITDA year-on-year change?
Over the past year, MCRB EV/EBITDA has changed by +126.25 (+97.85%)